Summary

Eligibility
for people ages 13-17 (full criteria)
Location
at UCLA
Dates
study started
estimated completion
Principal Investigator
by Marc J. Weintraub, PhD (ucla)

Description

Summary

Although cognitive-behavioral therapy (CBT) has shown efficacy in reducing symptoms and rates of mood relapse in adolescents at high risk for severe mood disorders (SMD; i.e., bipolar I/II disorder and recurrent or unremitting major depression), a significant limitation to the CBT's efficacy is the low rate of participant adherence to the prescribed between-session homework tasks. Mobile health applications have the potential to improve adherence to and acceptance of treatment through embedded treatment content, skill-practice, thought and symptom monitoring, all of which are facilitated by reward contingencies and notifications. This study examines whether a mobile application-enhanced CBT can improve participant adherence and treatment acceptance for adolescents at high risk for SMD.

Official Title

Mobile-enhanced Transdiagnostic Group Treatment for Adolescents at Risk for Severe Mood Disorders

Keywords

Adolescents Mood Disorders cognitive behavioral therapy (CBT) mobile health (mHealth) Group treatment

Eligibility

You can join if…

Open to people ages 13-17

  1. Meet DSM-5 criteria for at least one past major depressive disorder, persistent depressive disorder, or unspecified bipolar disorder
  2. Be 13-17 years old
  3. English speaking and able to complete written questionnaires
  4. Ability to attend pre-determined group session time(s)
  5. Access to a smartphone to engage with the study app
  6. Medication usage is acceptable, but not required

You CAN'T join if...

  1. Regular use or current abuse of a psychoactive drug
  2. Evidence of behavioral problems that are thought to interfere with group treatment
  3. Suicidality that requires more intensive treatment
  4. Meeting DSM 5 criteria for bipolar I or II disorder, a psychotic disorder, or significant psychiatric symptoms (e.g., self-injurious behavior) that require more intensive treatment
  5. Concurrent participation in cognitive-behavioral therapy
  6. Inability to travel to study sessions and assessments

Location

  • UCLA Semel Institute accepting new patients
    Los Angeles California 90095-8353 United States

Lead Scientist at University of California Health

  • Marc J. Weintraub, PhD (ucla)
    HS Clinical Instructor, Psychiatry and Biobehavioral Sciences. Authored (or co-authored) 27 research publications.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT04887155
Study Type
Interventional
Last Updated